Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fallara

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Urologic Oncology|June 6, 2022
Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinomaAlberto Martini, Giuseppe Fallara, Antony A Pellegrino, et al.
Urologic Oncology|June 6, 2022
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinomaGiuseppe Basile, Giuseppe Rosiello, Alessandro Larcher, et al.
Research and Reports in Urology|June 26, 2025
Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine TherapiesAlberto Quistini, Francesco Chierigo, Giuseppe Fallara, et al.
Prostate Cancer and Prostatic Diseases|September 8, 2025
Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysisFrancesco Chierigo, Giuseppe Fallara, Massimiliano Depalma, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2022
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomyGiuseppe Rosiello, Chiara Re, Alessandro Larcher, et al.
Urologic Oncology|February 10, 2022
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinomaGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologic Oncology|April 21, 2024
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancerFrancesco Cei, Alessandro Larcher, Giuseppe Rosiello, et al.
The World Journal of Men'S Health|July 19, 2024
Contemporary Diagnostic Work-Up for Male Infertility: Emphasizing Comprehensive Baseline AssessmentEdoardo Pozzi, Federico Belladelli, Christian Corsini, et al.
World Journal of Urology|September 20, 2022
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?Giuseppe Fallara, Alessandro Larcher, Giuseppe Rosiello, et al.
European Urology Focus|April 17, 2023
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning CurvePaolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Urologic Oncology|June 6, 2022
Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinomaAlberto Martini, Giuseppe Fallara, Antony A Pellegrino, et al.
Urologic Oncology|June 6, 2022
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinomaGiuseppe Basile, Giuseppe Rosiello, Alessandro Larcher, et al.
Research and Reports in Urology|June 26, 2025
Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine TherapiesAlberto Quistini, Francesco Chierigo, Giuseppe Fallara, et al.
Prostate Cancer and Prostatic Diseases|September 8, 2025
Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysisFrancesco Chierigo, Giuseppe Fallara, Massimiliano Depalma, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2022
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomyGiuseppe Rosiello, Chiara Re, Alessandro Larcher, et al.
Urologic Oncology|February 10, 2022
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinomaGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologic Oncology|April 21, 2024
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancerFrancesco Cei, Alessandro Larcher, Giuseppe Rosiello, et al.
The World Journal of Men'S Health|July 19, 2024
Contemporary Diagnostic Work-Up for Male Infertility: Emphasizing Comprehensive Baseline AssessmentEdoardo Pozzi, Federico Belladelli, Christian Corsini, et al.
World Journal of Urology|September 20, 2022
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?Giuseppe Fallara, Alessandro Larcher, Giuseppe Rosiello, et al.
European Urology Focus|April 17, 2023
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning CurvePaolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al.
Pageof 15